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Abstract
Substantia nigra pars compacta (SNpc) is highly sensitive to normal aging and selectively degenerates in Parkinson’s disease
(PD). Until now, molecular mechanisms behind SNpc aging have not been fully investigated using high throughput
techniques. Here, we show early signs of aging in SNpc, which are more evident than in ventral tegmental area (VTA),
a region adjacent to SNpc but less affected in PD. Aging-associated early changes in transcriptome were investigated
comparing late middle-aged (18 months old) to young (2 months old) mice in both SNpc and VTA. A meta-analysis of
published microarray studies allowed us to generate a common ‘‘transcriptional signature’’ of the aged ($ 24 months old)
mouse brain. SNpc of late-middle aged mice shared characteristics with the transcriptional signature, suggesting an
accelerated aging in SNpc. Age-dependent changes in gene expression specific to SNpc were also observed, which were
related to neuronal functions and inflammation. Future studies could greatly help determine the contribution of these
changes to SNpc aging. These data help understand the processes underlying SNpc aging and their potential contribution
to age-related disorders like PD.
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Introduction
Brain aging is a slow and progressive process, which results in
impairment of memory, cognitive and motor functions, and
eventually, cell death. In addition, aging is the major risk factor for
neurodegenerative diseases, such as Alzheimer’s disease (AD) and
Parkinson’s disease (PD). During the aging process, increases in
oxidative, metabolic, and ionic stresses result in neuronal
dysfunction and cell death [1].
Different brain regions age differently depending on their
specific structure and function. Dopaminergic (DA) neurons in the
substantia nigra pars compacta (SNpc) are highly sensitive to aging
and are progressively and selectively degenerated in PD. Loss of
SNpc DA neurons in the elderly occurs at a rate of ,5% per
decade [2–4] and is associated with declined motor function [5,6].
Accelerated aging in SNpc has been supposed to be a consequence
of the particular metabolic and electrophysiological properties of
DA neurons in this region [7–10]. Gene expression profiling of DA
neurons in SNpc of elderly individuals indicates an up-regulation
of cAMP response element-binding (CREB) and retinoic acid
receptors (RAR)-mediated signaling and neuronal function,
probably functioning as a compensatory response to aging [11].
In addition, studies on human and rodent individual genes have
demonstrated the implication of inflammation [12], iron metab-
olism [13], DA neuronal function [14–22], and vascularization
[23] in SNpc aging.
Recent advances in global-genome expression techniques
provide a bona fide way to study molecular changes underlying
brain aging in both human and rodents [11,24–32]. However,
until now molecular mechanisms underlying SNpc aging have not
been addressed experimentally in rodent models using high
throughput techniques. Therefore, the goal of the current study
was to investigate changes in gene expression in SNpc during early
aging. Late middle-aged mice (18 months old) without major
behavioral alteration were compared with young (2 months old)
animals. Side-by-side global gene expression analyses of SNpc and
ventral tegmental area (VTA), a DA region adjacent to SNpc but
less affected than SNpc in PD, were carried out using microarray
techniques. A meta-analysis of published microarray studies
resulted in the generation of a ‘‘transcriptional signature’’, a list
of common age-associated genes in aged ($ 24 months old) mouse
brain. In comparison with this transcriptional signature, acceler-
ated aging was suggested in SNpc of late middle-aged mice.
Materials and Methods
Animals and Ethics Statement
Wild-type C57BL/6 mice were housed at regulated tempera-
ture (2261uC) in a 12 h light/dark cycle with ad libitum access to
food and drink. All experiments were performed according to
guidelines from the European Community (Council Directive 86/
609/EEC) and were approved by the ethical committee of the
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‘‘Hospital Universitario Virgen del Rocı´o’’. All efforts were made
to minimize suffering. Mean life span of C57BL/6 mice are
around 26 to 30 months [33,34]. Three age groups of mice were
used in microarray analysis: young (2 months old), middle aged (10
months old), and late-middle aged (18 months old) mice. Four
replicates were included in each age group and each replicate was
pooled from either 4 or 5 mice (SNpc: 4 mice/replicate64
replicates63 age groups; VTA: 5 mice/replicate64 replicate-
s63 age groups). Mice were deeply anesthetized by intraperitoneal
injection of sodium thiopental before decapitation, followed by
brain extraction. Brains were further processed for either
immunohistochemical analyses or gene expression studies using
microarray or real-time quantitative PCR techniques.
Behavioral Test
To evaluate the motor function, open-field analysis was
performed as described previously [35]. Mouse movement in
a box of 22.5622.5 cm floor and 42 cm-high walls was recorded
for 60 min using an automatic tracking system (SMART, Panlab)
and analyzed using the SMART software (version 2.5.14). Weight
of each mouse was measured before the behavioral test.
SNpc and VTA Dissection, RNA Extraction, Amplification,
and Microarray Analysis
Freshly dissected brain was embedded in gelatin. Coronal
sections with a thickness of 500 mm were cut with a vibratome
(Leica). According to the mouse brain stereotaxic atlas [36], SNpc
and VTA (from 22.5 to 24.0 mm of bregma) were dissected
manually under a microscope, quickly frozen with liquid nitrogen,
and stored at 280uC for total RNA isolation. For each replicate,
total RNA was isolated from pooled SNpc (n= 4 mice) or VTA
(n= 5 mice) using RNeasy micro kit (Qiagen) according to the
manufacturer’s instruction. The quality of RNA was analyzed
using Agilent 2100 Bioanalyzer (Agilent). RNA samples with RNA
integrity number (RIN) [37] higher than 7 were further processed
for microarray analysis.
A total of 50 ng total RNA of each replicate was applied for
synthesis, labeling, and hybridization of cRNA using two-cycle
target labeling assay (Affymetrix). Gene expression was studied
using GeneChip Mouse Genome 430 2.0 Array (Affymetrix)
following the manufacturer’s instruction. Images were processed
with Affymetrix GeneChip Operating Software 1.4.0.036 (SNpc)
or GeneChip Command Console 2.0 (VTA).
Statistical analysis of the microarray data was performed using
Babelomics software v4.2 (Medina et al., 2010). Raw expression
values (CEL files) were reprocessed for background correlation,
normalization, and summarization of probe values using the
Robust Multi-chip Average (RMA) algorithm [38]. Differentially
expressed genes between conditions were determined by LIMMA,
a moderated t-test oriented to experiments with few biological
replicates [39,40]. p values were adjusted to control the false
discovery rate (pFDR) using the Benjamini and Hochberg method
[41]. Gene expression was considered different between groups
with pFDR ,0.05 and fold change.1.3. Microarray raw data was
submitted to Gene Expression Omnibus (GEO) database (acces-
sion number GSE45045).
Gene ontology, including biological functions and pathways
over-represented by the differentially expressed genes, was
analyzed using Ingenuity Pathway Analysis (IPA, September
2011 version, Ingenuity system). The significance of pathway and
function over-representation was calculated using Fisher’s exact
test, and p values ,0.05 were considered significant.
Microarray Meta-analysis
To determine common changes in gene expression in aged
mouse brain, literature searches in National Center for Bio-
technology Information (NCBI) PubMed and dataset searches in
NCBI gene expression omnibus (GEO) [42] and ArrayExpress
(EBI) [43] were conducted to identify studies of gene expression
profiling in aged mouse brain. Studies’ inclusion criteria were: 1)
compared brain or a brain region between young (2–5 months old)
and aged (24–30 months old) mice; 2) studied transcripts on
a genome-wide base; 3) used Affymetrix gene expression
GeneChip Mouse Genome 430 2.0 Array, the same one used in
the current study. Four studies met the inclusion criteria, which
used either C57BL/6 strain or a hybrid strain of C57BL/6. Either
whole brain, brain without cerebellum and brain stem, or
neocortex was used in each study. Raw microarray data (CEL
files) were obtained from public repositories [26,44,45] or authors
of the study [46]. To avoid the difference in data processing and
statistic analysis among studies, these studies were re-analyzed
using the same method that was used to analyze the microarray
data of SNpc and VTA. Briefly, raw expression values (CEL files)
were reprocessed using the RMA algorithm and differentially
expressed genes between conditions were determined by LIMMA.
To generate a common list of age-associated genes in mouse
brain, the list of genes with differential expression from each study
was imported into IPA. When a gene appeared in at least three of
the four lists, that gene was included into a common list, which was
named as ‘‘transcriptional signature’’ of the aged mouse brain.
Genes with differential expression in SNpc and VTA were
compared with this transcriptional signature and the potential
difference in transcriptional signature representation between
SNpc and VTA was determined by Chi-square test. In addition,
biological pathways and functions over-represented by the
differentially expressed genes in SNpc and VTA were also
compared with those over-represented by the transcriptional
signature. The potential difference in over-represented functions of
transcriptional signature between SNpc and VTA was evaluated
by Kruskal-Wallis one-way analysis of variance on ranks followed
by Tukey test. A p value of ,0.05 was considered significant.
Immunohistochemistry
To determine whether the correct regions were dissected for
gene expression profiling, brain sections after SNpc or VTA
dissection were fixed with 4% paraformaldehyde and then
incubated with tyrosine hydroxylase (TH) antibody (rabbit poly-
clonal, 1:2000 dilution, Novus Biologicals). Immunoreactivity was
detected with 3,3-diaminobenzidine (DAB) using Envision+
System-HRP (Dako Cytomation) according to the manufacturer’s
instruction. Mouse brain stereotaxic atlas [36] was used as the
reference to localize SNpc and VTA.
To detect glial fibrillary acidic protein (GFAP) expression,
mouse brains were fixed with 4% paraformaldehyde in PBS and
paraffin-embedded. Coronal sections with a thickness of 20 mm
were cut with microtome (Leica). Immunoreactivity against GFAP
antibody (rabbit polyclonal, 1:5000 dilution, Dako Cytomation)
was detected with DAB using Envision+ System-HRP (Dako
Cytomation) [47]. The same sections were also incubated with TH
antibody (mouse monoclonal, 1:50 dilution, Sigma), followed by
the fluorescent secondary antibody Alexa 568 (1:500 dilution,
Invitrogen) in order to localize SNpc and VTA.
Real-time Quantitative PCR
To determine the SNpc and VTA dissection accuracy, total
RNA was isolated from SNpc and VTA of 2 months old mice.
SNpc or VTA from 5 mice were pooled for each replicate. cRNA
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was amplified using Ambion WT Expression Kit (Life Technol-
ogies). 20 ng cRNA was copied to cDNA using QuantiTect
Reverse Transcription Kit (Qiagen) in a final volume of 20 ml.
Real-time quantitative PCR reactions were performed in
a 7500 Fast Real Time PCR System (Life Technologies). PCR
reactions were performed in duplicates in a total volume of 20 ml
containing 1 ml of cDNA solution and 1 ml of Calb1 Taqman
probe (Life Technologies). Actb was also estimated in each sample
to normalize the amount of cRNA input in order to perform
relative quantifications.
To validate the microarray results, 20 ng cRNA after the first
amplification cycle of cRNA synthesis for the microarray analysis
was copied to cDNA using Ambion WT Expression Kit (Life
Technologies) in a final volume of 20 ml. Real-time quantitative
PCR reactions were performed in a 7500 Fast Real Time PCR
System (Life Technologies). PCR reactions were performed in
duplicates in a total volume of 20 ml containing 1 ml of cDNA
solution and 1 ml of Taqman probe of the specific gene (Life
Technologies). Actb was also estimated in each sample to normalize
the amount of total RNA input in order to perform relative
quantifications. In addition, an independent cohort of animals was
also used to validate the microarray results following the same
procedures explained above.
Allen Mouse Brain Atlas searching
Gene expression pattern in mouse brain was searched in the
Allen Mouse Brain Atlas website (Seattle, Washington: Allen
Institute for Brain Science, http://mouse.brain-map.org) [48].
Genes with age-dependent changes in expression in SNpc were
searched in the atlas to determine whether their expression was
enriched in SNpc in comparison to other brain nuclei. Images
from two months old animals were used for the analysis.
Statistical Analysis
For behavioral test and real-time quantitative PCR, data were
presented as mean 6 standard error of the mean (s.e.m.). Real-
time quantitative PCR was analyzed with Student’s t-test.
Kolmogorov-Smirnov test was first performed to test whether
the data distribution of behavioral analysis was normal and
student’s t-test was used to detect potential difference between
groups. Linear regression was applied to determine whether the
behavioral change was dependent on weight in old animals. A p
value of ,0.05 was considered significant. Statistical analyses of
microarray studies and meta-analysis were described in their
corresponding sections.
Results
Motor Performance of Late Middle-aged Mice
Motor behavior was first examined in 18 months old mice,
which are considered late middle-aged, to determine whether this
is the right age to study early molecular changes during aging.
Animal’s weight was also measured to avoid confounding factors.
Female mice weighed 20.5761.20 g (2 months old) and
29.1360.72 g (18 months old), whereas male mice weighed
24.0560.45 g (2 months old) and 35.6061.13 g (18 months old).
As evaluated by open field analysis, traveled distance was similar
between 18 and 2 months old mice, indicating a lack of major
change in motor function. Although not significant (p,0.05),
a trend of decrease in resting time was observed in 18 months old
mice. On the other hand, average speed of movement was
decreased in the aged group compared with the young one
(p,0.05). After adjusted by weight, as analyzed by linear
regression, the average speed in 18 months old mice was still
slower than that in 2 months old mice (p,0.05), indicating that
subtle changes in motor function had already started to occur in 18
months old mice. Overall, the lack of major change in motor
function in 18 months old mice supported the decision of using
mice with this age to study initial changes during aging.
Effect of Age on Gene Expression Profile in SNpc
In order to study the global effect of aging on gene expression
profiles in SNpc and VTA, which depends on the whole cell
populations in each nucleus, complete regions instead of DA
neurons in each area were dissected from mouse brain. To
determine whether the regions were correctly selected, brain
sections after the dissection were compared with a section without
dissection (Figure 1). As shown by the TH immunoreactivity,
which was used to label DA neurons in SNpc and VTA, SNpc was
correctly dissected without contamination from VTA (Figure 1B)
and vice versa (Figure 1D). High expression of calbindin (Calb1) in
VTA has been reported compared to SNpc [49]. In agreement
with the published data, Calb1 gene expression was found to be
higher from dissected VTA than from SNpc as determined by
real-time quantitative PCR (Figure 1E). Both results from
immunochemistry and quantitative PCR indicated an accurate
SNpc and VTA dissection.
Microarray analyses were then carried out to study the aging
effect on transcriptome in SNpc. GeneChip Mouse Genome 430
2.0 Array (Affymetrix) was used, which is comprised of over
45,000 probe sets and represents over 34,000 mouse genes. As
shown in the volcano plot in Figure 2A, differentially expressed
genes between 2 and 18 months old mice were distributed in the
top left (pFDR ,0.05 and fold change,-1.3) and top right (pFDR
,0.05 and fold change .1.3) sections of the plot. Among the 116
differentially expressed probe sets, 99 genes were identified using
IPA. These data demonstrated the existence of changes in gene
expression profile of mouse SNpc during the early aging process.
Real time quantitative PCR was performed to validate the
microarray results. Fourteen genes with the fold change .1.3 and
relatively high intensity of raw microarray hybridization signals
were selected. Changes in gene expression were confirmed in 9 of
14 genes (64%) using the same RNA samples as microarray
(Figure 3). In addition, an independent cohort of mice was also
used for the quantitative PCR validation and 10 of 14 genes (71%)
were confirmed (Figure 3). Combining the microarray RNA and
new RNA samples, 13 of 14 (93%) genes were validated by
quantitative PCR.
It was then determined whether the age-dependent genes were
expressed in SNpc when compared in the same slices with other
adult mice brain nuclei by searching the Allen Mouse Brain Atlas,
in which gene expression was detected by in situ hybridization.
Although quantitative analyses are not possible with this
technique, a qualitative comparison was performed. Thirteen of
the 99 genes were strongly expressed in SNpc, and 47 of the 99
genes were weakly expressed. Combining the strongly and weakly
expressed genes, 60 of 99 genes (61%) were detected by in situ
hybridization. Expression of the remaining genes was either not
detected, possibly due to the technique’s limitation on sensibility,
or not available (Supplementary Table S1).
To determine the time course of age-dependent changes in gene
expression in SNpc, microarray data were also compared between
2 and 10 months old, and 10 and 18 months old mice. Only 3
genes were up-regulated comparing 10 and 2 months groups (3%),
which were also increased when comparing 18 and 2 months old
groups. No difference in gene expression was detected between 18
and 10 months old groups. These data indicated a gradual age-
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dependent change in transcriptome in SNpc from 2 to 18 months
old mice.
To investigate the nature of genes with differential expression in
young and aged mice, gene ontology analysis was carried out using
IPA. Top 5 biological functions and canonical pathways were
listed in Table 1, indicating that age-dependent genes in mouse
SNpc were mainly involved in inflammation, immunological
diseases, and cell death. In addition, GFAP immunoreactivity was
Figure 1. SNpc and VTA dissection from mouse brain. Brain sections were labeled against tyrosine hydroxylase antibody without (A) and after
(B) SNpc dissection, and without (C) and after (D) VTA dissection. Scale bar: 500 mm. E. Relative Calb1 mRNA level. *, p,0.05 comparing VTA to SNpc
(n=4 in each group).
doi:10.1371/journal.pone.0062456.g001
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increased in the SNpc of 18 months old mice (n= 3, Figure 4),
further supporting the occurrence of a glial response in mice of
that age.
Gene Expression Profiling in VTA
Microarray analyses were also carried out to determine the
aging effect on transcriptome in VTA, a DA region adjacent to
SNpc. The data distribution was shown in Figure 2B. Comparing
18 and 2 months old mice, 4462 probe sets were differently
expressed, among which 3675 genes had been identified using IPA
(pFDR ,0.05 and fold change .1.3). Gene ontology analysis
indicated that age-dependent genes in VTA were mainly involved
in neurological diseases, post-translational modification, cell cycles,
as well as nervous system development and function. This pattern
is different from that found for genes in SNpc (Table 1).
To determine the time course of age-induced changes in VTA
gene expression, microarray data were also compared between 2
and 10, and 10 and 18 months old mice. Gene expression was
changed in 985 probe sets (891 genes) from 2 to 10 months old
mice (24.2%), whereas only one gene was differentially expressed
from 10 to 18 months old mice. Genes differentially expressed
between 2 and 10 months old mice were mainly implicated in
neurological diseases, tissue development, cell cycle, embryonic
and organ development (Supplementary Table S2). Among them,
846 genes were also detected when comparing 2 and 18 months
groups. The large number of differentially expressed genes
Figure 2. Volcano plots illustrating differential gene expression in SNpc (A) & VTA (B) comparing late middle-aged (18months old)
to young (2month old) mice. Differentially expressed genes were distributed in the top left and top right sections of each figure, corresponding
pFDR ,0.05 and fold change,21.3 and pFDR ,0.05 and fold change .1.3, respectively.
doi:10.1371/journal.pone.0062456.g002
Figure 3. Validation of microarray results in SNpc by real time quantitative PCR. Relative log2 fold changes of mRNA were presented
comparing late middle-aged (18months old) to young (2month old) mice. Positive numbers corresponded to up-regulated genes, whereas negative
numbers indicated down-regulated genes. *, p,0.05 comparing 18 to 2 months old mice using Student’s t-test. n=4 replicates for each age group.
doi:10.1371/journal.pone.0062456.g003
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between 2 and 10 months old mice suggests a maturation of VTA
during this post-natal adult period.
Comparison to Transcriptional Signature of the Aged
Mouse Brain
We also investigated whether genes differentially expressed in
late middle-aged SNpc coincide with those in aged ($ 24 months)
mouse brain. To this end, common changes in gene expression in
aged mouse brain were first evaluated by re-analyzing four
published microarray studies [26,44–46] using the same method
and criteria as in the current study (see Materials and
methods). By comparing the lists of differentially expressed
genes from each study using IPA, a ‘‘transcriptional signature’’ of
61 common age-associated genes, which appeared in at least three
of the four studies, was generated (supplementary Table S3).
Twenty-four of the 99 (24.2%) genes with differential expression in
SNpc of 18 months old mice were present in the transcriptional
signature of $ 24 months old mouse brain. In contrast, only 36 of
the 3675 (0.1%) genes differentially expressed in the 18-month old
VTA also appeared in the transcriptional signature. In order to
perform a fair comparison between SNpc and VTA, only the top
120 probe sets with the lowest pFDR values in VTA were
Table 1. Gene ontology analysis of age-dependent genes in SNpc and VTA comparing 18 to 2 months old mice.
Top 5 functions/pathways p value No. molecules or ratio
A. SNpc
Molecular and cellular functions
Cell-to-cell signaling and interaction 8.21e-12–7.84e-03 36
Cellular movement 1.37e-09–7.73e-03 29
Cellular compromise 1.02e-07–4.51e-03 16
Cellular growth and proliferation 8.62e-07–7.84e-03 34
Cell death 2.19e-06–7.54e-03 30
Physiological system development and function
Immune cell trafficking 1.37e-09–7.54e-03 26
Hematological system development and function 2.62e-08–7.84e-03 38
Tissue morphology 1.01e-06–7.54e-03 24
Renal and urological system development and function 4.39e-06–4.39e-06 5
Tissue development 6.69e-06–7.54e-03 38
Canonical pathways
IL-10 signaling 3.13e-04 4/78 (0.051)
Systemic lupus erythematosus signaling 3.2e-04 6/228 (0.026)
Complement system 4.79e-04 3/35 (0.086)
B cell receptor signaling 5.68e-04 5/156 (0.032)
Dendritic cell maturation 7.85e-04 5/188 (0.027)
B. VTA
Molecular and cellular functions
Post-translational modification 1.03e-19–5.27e-03 399
Cell cycle 4.11e-18–5.44e-03 415
Cellular assembly and organization 1.68e-13–5.31e-03 477
Cellular function and maintenance 1.68e-13–5.31e-03 399
Gene expression 5.37e-13–4.09e-03 599
Physiological system development and function
Tissue development 9.89e-09–4.59e-03 490
Nervous system development and function 2.33e-08–5.27e-03 420
Connective tissue development and function 3.01e-08–3.94e-03 142
Organismal development 4.46e-06–3.94e-03 454
Embryonic development 2.72e-05–3.94e-03 197
Canonical pathways
Molecular mechanisms of cancer 5.45e-10 100/379 (0.264)
Breast cancer regulation by stathmin1 2.04e-08 63/210 (0.300)
Ephrin receptor signaling 3.21e-08 57/200 (0.285)
Production of nitric oxide and reactive oxygen species in macrophages 4.48e-07 51/187 (0.273)
Integrin signaling 5.79e-07 59/210 (0.281)
doi:10.1371/journal.pone.0062456.t001
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considered, and in this case, 9 of 114 (7.9%) genes were included
in the transcriptional signature of aged mouse brain. Comparing
the later ratio in VTA to that in SNpc, the transcriptional
signature of aged brain ($ 24 months old) was more represented in
SNpc than VTA of 18 months old mice (x2 = 10.82, df = 1,
p,0.05).
Biological functions over-represented by the transcriptional
signature of the aged brain were compared with those of SNpc and
VTA. As shown in Figure 5A, the top 15 functions over-
represented by the transcriptional signature were mainly impli-
cated in inflammatory and immune responses and were also over-
represented in SNpc and VTA. However, when only the top 5
functions were considered, there was a similarity between the
transcriptional signature and SNpc (p.0.05), but not between the
signature and VTA (p,0.05). When only the top 120 probe sets in
VTA were considered (Figure 5B), p values of all the top 15
functions were similar between SNpc and signature (p.0.05), but
not between VTA and the signature (p,0.05). These results
indicate that gene expression profile in SNpc of 18 months old
mice is similar to the transcriptional signature of the $ 24 months
old mouse brain, suggesting an early aging in SNpc.
Age-associated Genes Specific to SNpc
A list of age-associated genes specific to SNpc was then
generated using IPA. Comparing the age-associated genes in SNpc
to those in VTA and the transcriptional signature of the aged
mouse brain, a list of 43 age-associated genes specific to SNpc was
obtained, which were in neither the signature nor the VTA list
(Table 2). Using gene ontology analysis, it was found that the top 5
biological functions and canonical pathways over-represented by
these genes were mainly related to inflammatory disease, nervous
system development and function, cellular growth and pro-
liferation (Table 3). These results suggest that in addition to
general brain changes during aging, differential gene expression
specific to SNpc in comparison to that of the whole brain of aged
mice also occurs. However, the magnitude of the SNpc specific
changes was small and further independent validation will be
required.
Discussion
Changes in transcriptome during the initial stage of brain aging
have not been fully addressed. Information about early SNpc
aging, a region selectively degenerated in PD, is also very scant.
Therefore, we have studied gene expression profile in mouse SNpc
during the initial stage of aging in comparison with that in VTA
from mice of the same age, and with the published data of aged
mouse brain as well. Human studies of frontal cortex suggest that
aging starts in young adult life (middle-aged people .40 years old)
[28]. A progressive decline in locomotor activity, as determined by
open field analysis, has been observed previously from 6 to 24
months old mice [24]. In the current study, 18 months old mice
lacking major changes in locomotor activity was used to avoid
confusing factors like dramatic cell death and pathological changes
associated with advanced aging. Whole SNpc or VTA regions
instead of dispersed DA neurons was analyzed, which allowed us
to study in each region not only the contribution from DA
neurons, but also from non-DA neurons and glia cells. The genes
related to inflammation demonstrated the contributions of glia/
microglia. On the other hand, neuronal gene expression was also
modified and some genes were up-regulated (Table 2), demon-
strating the contribution of neurons. The results demonstrated that
even in late middle-aged mice, there are changes in gene
expression suggesting premature aging in SNpc.
Effect of Age on Gene Expression Profile in SNpc
A total of 99 genes were found to be differentially expressed in
SNpc comparing 18 to 2 months old mice. The magnitude of
changes in gene expression was relatively small, with the largest
fold change less than 6, which is similar to previously published
studies [27,50]. A complex region, containing neurons, astroglia,
and other cells were analyzed in our study, which could dilute
Figure 4. Representative immunohistochemical staining of GFAP in SNpc. A and B, immuno-staining against GFAP antibody. A’ and B’,
immuno-fluorescent staining against TH antibody. A’’ and B’’, merging of immuno-stainings against GFAP and TH antibodies, the later was
represented with a pseudo-color. SNpc was highlighted in each panel. Inset, a higher magnification of SNpc for each picture. Scale bar, 200 mm.
doi:10.1371/journal.pone.0062456.g004
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specific effects of aging on dopaminergic cells. Therefore, a 1.3 fold
change in the whole SNpc region could result from a fold change
much higher than 1.3 in dopaminergic neurons. Despite of the
relatively small magnitude of changes, 13 of 14 genes were
validated using real time quantitative PCR including those with
small fold of changes such as Hexb, Il33, and Enc1 (Figure 3). The
qualitative study of gene expression pattern in mouse brain (Allen
Brain Atlas) also supported the microarray results (Supplementary
Table S1). Furthermore, 48 of 99 genes (48%) with altered
expression in SNpc were also differentially expressed in VTA,
a neighboring region with a similar cell population to SNpc.
Twenty-four of 99 (24.2%) genes were also over-presented in aged
mouse brain (see discussion below). Taken together, these data
validated the microarray results.
Gene Expression Profiling in VTA
Comparing 2 and 18 months old mice, 3675 genes were
differently expressed in VTA, which was much higher than that in
SNpc (99 genes). A possible explanation of the difference in
number of genes could be sample preparation. Due to the limited
amount of VTA tissue obtained from each mouse, VTA from
5 mice had to be pooled for each replicate instead of 4 mice for
SNpc. The increase in the number of mice used in each replicate
of VTA could decrease the variability among replicates, leading to
Figure 5. Top 15 biological functions over-represented in aged ($ 24 months old) mouse brain in comparison to SNpc and VTA in
late middle-aged (18 months old) mice. A. VTA; B. Top 120 probe sets with the lowest pFDR values in VTA. Threshold: p= 0.05.
doi:10.1371/journal.pone.0062456.g005
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the detection of high number of differentially expressed genes
when compared between groups. However, the magnitude of
changes (fold change) in gene expression in SNpc was similar to
that in VTA (Figure 2), indicating that the results of differentially
expressed genes in SNpc are reliable, although it is possible that
the number of differentially expressed genes in SNpc could be
underestimated.
Intrinsic properties of each brain nuclei could also contribute as
a major cause of difference in the number of differentially
expressed genes found between SNpc and VTA. Indeed, different
Table 2. Age-associated genes specific to mouse SNpc.
Gene symbol Entrez gene description Fold change* pFDR
1600021P15Rik RIKEN cDNA 1600021P15 gene 21.40 0.041
AA467197 expressed sequence AA467197 1.60 0.048
Ang angiogenin, ribonuclease, RNase A family, 5 1.61 0.011
Arhgap30 Rho GTPase activating protein 30 1.42 0.047
Arhgap36 Rho GTPase activating protein 36 21.59 0.024
Arhgef37 Rho guanine nucleotide exchange factor (GEF) 37 1.60 0.046
Baiap3 BAI1-associated protein 3 21.45 0.048
Bcl2a1a B-cell leukemia/lymphoma 2 related protein A1a 1.84 0.030
Ctbs chitobiase, di-N-acetyl- 1.49 0.048
Cybb cytochrome b-245, beta polypeptide 2.53 0.010
Cyp1b1 cytochrome P450, family 1, subfamily B, polypeptide 1 1.56 0.040
Cyp51 cytochrome P450, family 51 21.38 0.047
Defb7 defensin beta 7 1,99 0.017
Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1 1.73 0.047
Egr1 early growth response 1 21.90 0.003
Ehbp1l1 EH domain binding protein 1-like 1 21.39 0.038
Emr1 egf-like module containing, mucin-like, hormone receptor-like sequence 1 1.61 0.046
Enc1 ectodermal-neural cortex 1 21.43 0.017
Fam70a family with sequence similarity 70, member A 21.46 0.036
Fcgr3 Cd16, Fc gamma 3R Alpha, Fc Gamma R3, Fc Gamma R3 Alpha, Fcgr3a 1.46 0.030
Fos FBJ osteosarcoma oncogene 21.75 0.022
Gamt guanidinoacetatemethyltransferase 21.51 0.037
Gcnt1 glucosaminyl (N-acetyl) transferase 1, core 2 1.60 0.029
Glis3 GLIS family zinc finger 3 1.54 0.045
Gm16440 predicted gene 16440 1.65 0.017
Il2rg interleukin 2 receptor, gamma chain 1.80 0.047
Kctd1 potassium channel tetramerisation domain containing 1 21.44 0.048
Lilrb4 leukocyte immunoglobulin-like receptor, subfamily B, member 4 1.74 0.003
Naalad2 N-acetylated alpha-linked acidic dipeptidase 2 1.81 0.002
Ncf1 neutrophil cytosolic factor 1 1.54 0.047
Nell2 NEL-like 2 (chicken) 21.74 0.044
Nupr1 nuclear protein 1 1.42 0.041
Pdzrn3 PDZ domain containing ring finger 3 21.47 0.049
Prkg1 protein kinase, cGMP-dependent, type I 21.67 0.030
Pth2 parathyroid hormone 2 21.67 0.030
Rprm reprimo, TP53 dependent G2 arrest mediator candidate 21.55 0.031
Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 1.46 0.038
Shisa3 shisa homolog 3 (Xenopus laevis) 21.86 0.014
Tceal5 transcription elongation factor A (SII)-like 5 21.51 0.048
Tmeff2 transmembrane protein with EGF-like and two follistatin-like domains 2 21.32 0.048
Txlnb taxilin beta 1.53 0.042
Ube3a ubiquitin protein ligase E3A 21.86 0.038
Zbtb26 zinc finger and BTB domain containing 26 21.40 0.048
*Comparing 18 months old to 2 months old mice, positive numbers corresponded to up-regulated genes, whereas negative numbers indicated down-regulated genes.
doi:10.1371/journal.pone.0062456.t002
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brain regions age at different speed and respond to aging with
different molecular changes [25,27,32]. Unlike SNpc, in which
gene expression was barely changed from 2 to 10 months (3%),
changes in expression of 891 genes (24%) in VTA were detected
during the same period. Gene ontology analysis suggested that
these genes were related to tissue and organ development, cell
growth, and neuronal function (Supplementary Table S2),
suggesting a postnatal maturation of VTA and/or high plasticity
associated with VTA function. Specifically, TH, monoamine
oxidase B, and quinoid dihydropteridine reductase, which are
involved in DA receptor signaling pathway, were up-regulated.
Presenilin 1 (PSEN1, a component of c-secretase complex) and
calpain were also up-regulated, whereas b-secretase (BACE1) was
down-regulated. These enzymes are involved in the amyloid-
processing pathway. The decrease in b-secretase mRNA points to
a protective role against amyloid-mediated toxic effect in VTA
that could help to explain the resistance of this brain region in
neurodegenerative disorders. Recently, presenilin 1 has been
shown to be necessary for lysosomal proteolysis and autophagy
function, reinforcing a protective role of presenilin 1 induction in
VTA aging [51].
Comparison to Transcriptional Signature of the Aged
Mouse Brain: Gene List and Pathway Analysis
To our knowledge, no study about the effect of age on
transcriptome in mouse SNpc has been published, which makes it
impossible to compare our data with other mouse SNpc studies.
On the other hand, we hypothesized that at least some changes
should be common to all brain regions including SNpc. In order to
test this hypothesis, a list of 61 common age-associated genes
(transcriptional signature) in $ 24 months old mouse brain was
first generated (Table S3) and compared with the SNpc data. The
transcriptional signature was obtained by re-analyzing four
previously published microarray studies of aged mouse brain
(whole brain, brain without cerebellum and brain stem, or
neocortex) [26,44–46]. A meta-analysis of 4 studies is considered
to provide reliable information of common changes during aging,
since 3 to 8 studies have been used in similar meta-analyses
[25,26]. In addition, the variability was minimized using strict
criteria to select studies. VTA data from late middle-aged mice
were used as the reference data of early aging point to compare
with SNpc, since no sufficient published data were available to
generate another list of common age-associated genes in 18
months old mouse brain. The top 120 probe sets with the lowest
pFDR values in VTA were used to obtain a reasonable comparison
between SNpc and VTA since the number of differentially
expressed genes was different between SNpc and VTA. Genes in
the transcriptional signature of$ 24 months old mouse brain were
more represented in SNpc than in VTA of 18 months old mice,
suggesting an early aging in mouse SNpc. Some caution is needed
when comparing the aging effect on SNpc and VTA due to the
differential post-natal development in these regions.
Although comparison of gene lists has been commonly used to
analyze microarray data, pathway and function comparison could
give extra or even more accurate information than gene list
comparison since different genes being differentially expressed
could affect the same pathway or biological function [11,52]. In
agreement with the gene list analysis, comparison analysis of
pathways and functions also showed a higher similarity between $
24 months old mouse brain and SNpc from 18 months old mice
than that between $ 24 months old mouse brain and VTA from
18 months old mice (Figure 5), further supporting the existence of
an early aging in mouse SNpc. Inflammatory response is highly
represented by the transcription signature in $ 24 months old
mouse brain (Figure 5). The increased GFAP immunoreactivity
also supported the occurrence of inflammatory response in SNpc
of 18 months old mice (Figure 4). Although increased GFAP
immunoreactivity was also observed in other brain regions
including VTA, no changes in GFAP mRNA level in VTA was
detected in the current microarray study. A possible explanation is
Table 3. Gene ontology analysis of age-associated genes specific to SNpc.
Top 5 functions/pathways p value No. molecules or ratio
Molecular and cellular functions
Cell-to-cell signaling and interaction 6.17e-05–3.44e-02 14
Cellular growth and proliferation 1.09e-04–4.15e-02 16
Free radical scavenging 3.87e-04–3.45e-02 3
Gene expression 4.92e-04–4.15e-02 6
Cellular movement 5.74e-04–3.97e-02 13
Physiological system development and function
Nervous system development and function 3.26e-05–3.62e-02 9
Hematological system development and function 3.76e-04–4.15e-02 11
Humoral immune response 3.76e-04–3.79e-02 7
Tissue morphology 3.76e-04–3.44e-02 10
Immune cell trafficking 6.80e-04–3.97e-02 8
Canonical pathways
B cell receptor signaling 2.55e-03 3/156 (0.019)
IL-2 signaling 4.58e-03 2/58 (0.034)
IL-10 signaling 7.73e-03 2/78 (0.026)
Linoleic acid metabolism 1.11e-02 2/108 (0.019)
Metabolism of xenobiotics by cytochrome P450 1.92e-02 2/197 (0.010)
doi:10.1371/journal.pone.0062456.t003
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that the low levels of GFAP, as shown by immunoreactivity in
Figure 4, in SNpc of 2 months old mice made it easier to detect
any changes statistically. An increase in GFAP expression is also
observed in VTA of 18 months old mice (Figure 4). However,
these differences did not reach statistical significance in our
mRNA study probably indicating a change of smaller magnitude.
Age-associated Genes Specific to SNpc
In the current study, 43 age-associated genes were found to be
specific to SNpc (Table 2). Several biological functions over-
represented by these genes were also over-represented by the
transcriptional signature of $ 24 months old mouse brain.
Whether the effect of SNpc-specific genes on these functions is
similar to that of transcriptional signature remains to be examined
in future studies. On the other hand, the transcriptional signature
could be under-estimated, since only genes that were found to be
differentially expressed in at least three of four studies were
included. Therefore, it could not be ruled out that some of these
genes were also affected by age in other brain nuclei. Future
studies to replicate the current work not only including SNpc,
VTA, but also cortex could help clarify these doubts.
Conclusion
Our results suggest an early aging in mouse SNpc using
microarray techniques and comparative analyses of gene lists and
biological functions. These changes in SNpc during the initial
stage of aging partially overlap general changes observed in aged
mouse brain. In addition, changes specific to SNpc are described.
Identification of genes that are selectively regulated in the SNpc of
middle aged individuals could help to better understand the
function and intrinsic properties of SNpc and to explain the
selective sensitivity of SNpc to aging and PD.
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